Exact Mass: 430.0586

Exact Mass Matches: 430.0586

Found 33 metabolites which its exact mass value is equals to given mass value 430.0586, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Bicalutamide

4-Cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3-(trifluoromethyl)propionanilide

C18H14F4N2O4S (430.061)


Bicalutamide is only found in individuals that have used or taken this drug. It is an oral non-steroidal anti-androgen for prostate cancer. It binds to the androgen receptor.Bicalutamide competes with androgen for the binding of androgen receptors, consequently blocking the action of androgens of adrenal and testicular origin which stimulate the growth of normal and malignant prostatic tissue. L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BB - Anti-androgens D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

CMP-2-aminoethylphosphonate

(2-aminoethyl)[({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphinic acid

C11H20N4O10P2 (430.0655)


This compound belongs to the family of Pyrimidine Ribonucleoside Diphosphates. These are pyrimidine ribobucleotides with diphosphate group linked to the ribose moiety.

   

Calcium gluconate

Calcium gluconate

C12H22CaO14 (430.0635)


A - Alimentary tract and metabolism > A12 - Mineral supplements > A12A - Calcium > A12AA - Calcium C78275 - Agent Affecting Blood or Body Fluid > C29730 - Electrolyte Replacement Agent D - Dermatologicals

   

Calcium gluconate

Calcium bis(2,3,4,5,6-pentahydroxyhexanoic acid)

C12H22CaO14 (430.0635)


Food additive: firming agent, sequestrant, stabiliser, texturiser. Anticaking agent in powdered coffee↵↵Calcium gluconate is a mineral supplement. It is the form of calcium most widely used in the treatment of hypocalcemia. Calcium gluconate contains 9.3\\% calcium. It is also used to counteract an overdose of magnesium sulfate, often administered to pregnant women experiencing premature labor to slow or stop contractions. Excess magnesium sulfate can cause respiratory depression, for which calcium gluconate would be the antidote. Food additive: firming agent, sequestrant, stabiliser, texturiser. Anticaking agent in powdered coffee

   
   
   

SANGUINARINE SULFATE

SANGUINARINE SULFATE

C20H16NO8S+ (430.0597)


   

9-Acetoxymethyl-4,6-diformyl-3,8-dihydroxy-1-methyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-7-carbonsaeure|9-acetoxymethyl-4,6-diformyl-3,8-dihydroxy-1-methyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-7-carboxylic acid

9-Acetoxymethyl-4,6-diformyl-3,8-dihydroxy-1-methyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-7-carbonsaeure|9-acetoxymethyl-4,6-diformyl-3,8-dihydroxy-1-methyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-7-carboxylic acid

C20H14O11 (430.0536)


   

Galbinic acid

Galbinic acid

C20H14O11 (430.0536)


   

5-{4-[4-(5-pent-1,3-diynylthiophen-2-yl)-but-3-ynyloxy]-but-1-ynyl}-2,2-bithiophene|echinoetherthiophene

5-{4-[4-(5-pent-1,3-diynylthiophen-2-yl)-but-3-ynyloxy]-but-1-ynyl}-2,2-bithiophene|echinoetherthiophene

C25H18OS3 (430.052)


   

14-hydroxy-8beta-(3-chloro-2-hydroxyisobutyryloxy)-3-chlorodehydroleucodin|14-hydroxy-8beta-<3-chloro-2-hydroxyisobutyryloxy>-3-chlorodehydroleucodin

14-hydroxy-8beta-(3-chloro-2-hydroxyisobutyryloxy)-3-chlorodehydroleucodin|14-hydroxy-8beta-<3-chloro-2-hydroxyisobutyryloxy>-3-chlorodehydroleucodin

C19H20Cl2O7 (430.0586)


   

diphosphoric acid-1-(2-amino-ethyl ester)-2-(2-deoxy-cytidin-5-yl ester)|Diphosphorsaeure-1-(2-amino-aethylester)-2-(2-desoxy-cytidin-5-ylester)

diphosphoric acid-1-(2-amino-ethyl ester)-2-(2-deoxy-cytidin-5-yl ester)|Diphosphorsaeure-1-(2-amino-aethylester)-2-(2-desoxy-cytidin-5-ylester)

C11H20N4O10P2 (430.0655)


   

Bicalutamide

(2R)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide

C18H14F4N2O4S (430.061)


L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BB - Anti-androgens D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4405; ORIGINAL_PRECURSOR_SCAN_NO 4401 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4432; ORIGINAL_PRECURSOR_SCAN_NO 4429 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4382; ORIGINAL_PRECURSOR_SCAN_NO 4377 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4426; ORIGINAL_PRECURSOR_SCAN_NO 4422 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4399; ORIGINAL_PRECURSOR_SCAN_NO 4398 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4400; ORIGINAL_PRECURSOR_SCAN_NO 4397 CONFIDENCE standard compound; INTERNAL_ID 2349 CONFIDENCE standard compound; INTERNAL_ID 8615 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2809

   
   
   
   

N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(2-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide

N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(2-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide

C18H14F4N2O4S (430.061)


   

Ethylendiamintetraacetic acid,di-sodium-magnesium salt

Ethylendiamintetraacetic acid,di-sodium-magnesium salt

C10H20MgN2Na2O12 (430.0662)


   

Thiazolidine, 2-(4-methoxy-3-nitrophenyl)-3-(1-naphthalenylsulfonyl)- (9CI)

Thiazolidine, 2-(4-methoxy-3-nitrophenyl)-3-(1-naphthalenylsulfonyl)- (9CI)

C20H18N2O5S2 (430.0657)


   
   

sodium 1-amino-9,10-dihydro-9,10-dioxo-4-o-toluidinoanthracene-2-sulphonate

sodium 1-amino-9,10-dihydro-9,10-dioxo-4-o-toluidinoanthracene-2-sulphonate

C21H15N2NaO5S (430.0599)


   

5-[(2,4-Dinitrophenyl)amino]-2-anilinobenzenesulphonic acid

5-[(2,4-Dinitrophenyl)amino]-2-anilinobenzenesulphonic acid

C18H14N4O7S (430.0583)


   

Calcium 2,3,4,5,6-pentahydroxyhexanoate

Calcium 2,3,4,5,6-pentahydroxyhexanoate

C12H22CaO14 (430.0635)


   

N-[5-[[2-(2-methyl-2,3-dihydroindol-1-yl)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide

N-[5-[[2-(2-methyl-2,3-dihydroindol-1-yl)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide

C19H18N4O2S3 (430.0592)


   

1-(3,4-Dichlorophenyl)-3-[diethoxyphosphoryl(phenyl)methyl]urea

1-(3,4-Dichlorophenyl)-3-[diethoxyphosphoryl(phenyl)methyl]urea

C18H21Cl2N2O4P (430.0616)


   
   

CMP-2-aminoethylphosphonate

CMP-2-aminoethylphosphonate

C11H20N4O10P2 (430.0655)


   

5-[4-({4-[5-(penta-1,3-diyn-1-yl)thiophen-2-yl]but-3-yn-1-yl}oxy)but-1-yn-1-yl]-2,2'-bithiophene

5-[4-({4-[5-(penta-1,3-diyn-1-yl)thiophen-2-yl]but-3-yn-1-yl}oxy)but-1-yn-1-yl]-2,2'-bithiophene

C25H18OS3 (430.052)


   

8-chloro-6-(hydroxymethyl)-9-methyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl 3-chloro-2-hydroxy-2-methylpropanoate

8-chloro-6-(hydroxymethyl)-9-methyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl 3-chloro-2-hydroxy-2-methylpropanoate

C19H20Cl2O7 (430.0586)


   

{4-formyl-5,13,17-trihydroxy-7-methyl-9,15-dioxo-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3,5,7,12,14(18)-hexaen-12-yl}methyl acetate

{4-formyl-5,13,17-trihydroxy-7-methyl-9,15-dioxo-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3,5,7,12,14(18)-hexaen-12-yl}methyl acetate

C20H14O11 (430.0536)


   

7-[(acetyloxy)methyl]-4,15-diformyl-6,14-dihydroxy-12-methyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-5-carboxylic acid

7-[(acetyloxy)methyl]-4,15-diformyl-6,14-dihydroxy-12-methyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-5-carboxylic acid

C20H14O11 (430.0536)


   

(3ar,4r,9ar,9br)-8-chloro-6-(hydroxymethyl)-9-methyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl (2r)-3-chloro-2-hydroxy-2-methylpropanoate

(3ar,4r,9ar,9br)-8-chloro-6-(hydroxymethyl)-9-methyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl (2r)-3-chloro-2-hydroxy-2-methylpropanoate

C19H20Cl2O7 (430.0586)


   

[(17s)-4-formyl-5,13,17-trihydroxy-7-methyl-9,15-dioxo-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3,5,7,12,14(18)-hexaen-12-yl]methyl acetate

[(17s)-4-formyl-5,13,17-trihydroxy-7-methyl-9,15-dioxo-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3,5,7,12,14(18)-hexaen-12-yl]methyl acetate

C20H14O11 (430.0536)